Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Vyepti

PharmaCompass

01

Brand Name : Vyepti

Eptinezumab- JJMR

arrow
The Generic Rx Session
Not Confirmed

Brand Name : Vyepti

arrow
The Generic Rx Session
Not Confirmed

Eptinezumab- JJMR

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 15

2019 Revenue in Millions : 0

Growth (%) : New Launch

blank

02

Brand Name : Vyepti

Eptinezumab- JJMR

arrow
The Generic Rx Session
Not Confirmed

Brand Name : Vyepti

arrow
The Generic Rx Session
Not Confirmed

Eptinezumab- JJMR

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 75

2020 Revenue in Millions : 15

Growth (%) : 429

blank

03

Brand Name : Vyepti

Eptinezumab- JJMR

arrow
The Generic Rx Session
Not Confirmed

Brand Name : Vyepti

arrow
The Generic Rx Session
Not Confirmed

Eptinezumab- JJMR

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 145

2021 Revenue in Millions : 75

Growth (%) : 93

blank

04

Brand Name : Vyepti

Eptinezumab-jjmr

arrow
The Generic Rx Session
Not Confirmed

Brand Name : Vyepti

arrow
The Generic Rx Session
Not Confirmed

Eptinezumab-jjmr

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 244

2022 Revenue in Millions : 145

Growth (%) : 69

blank